1. Home
  2. PATH vs PTCT Comparison

PATH vs PTCT Comparison

Compare PATH & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UiPath Inc.

PATH

UiPath Inc.

HOLD

Current Price

$10.69

Market Cap

5.6B

Sector

Technology

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$81.46

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PATH
PTCT
Founded
2005
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
5.7B
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
PATH
PTCT
Price
$10.69
$81.46
Analyst Decision
Hold
Buy
Analyst Count
17
17
Target Price
$14.41
$80.65
AVG Volume (30 Days)
49.1M
2.0M
Earning Date
05-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
500.00
264.48
EPS
0.04
N/A
Revenue
$1,610,572,000.00
$264,734,000.00
Revenue This Year
$11.82
N/A
Revenue Next Year
$8.50
$17.70
P/E Ratio
$263.25
N/A
Revenue Growth
12.65
36.19
52 Week Low
$9.20
$43.18
52 Week High
$19.84
$87.50

Technical Indicators

Market Signals
Indicator
PATH
PTCT
Relative Strength Index (RSI) 51.07 64.42
Support Level $10.61 $73.41
Resistance Level $11.26 $87.50
Average True Range (ATR) 0.54 3.20
MACD -0.03 0.81
Stochastic Oscillator 63.93 70.44

Price Performance

Historical Comparison
PATH
PTCT

About PATH UiPath Inc.

UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform. The platform leverages a range of automation technologies, including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries, including claims processing, employee onboarding, invoice-to-cash, loan applications, and customer service. The company works in the Americas, Europe, the Middle East, and Africa, and Asia-Pacific, with the maximum revenue from the America.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: